Related Experiment Video
Updated: Jun 3, 2025

11:40
Simplified Reverse Genetics Method to Recover Recombinant Rotaviruses Expressing Reporter Proteins
Published on: April 17, 2020
8.6K
An improved reverse genetics system for rotavirus vaccine strain LLR using five plasmid vectors
Xiafei Liu1,2, Junjie Yu2,3, Shan Li2,3
1The First Clinical Medical Institute, Henan University of Chinese Medicine, Zhengzhou, Henan 450000, PR China.
The Journal of General Virology
|January 10, 2025
Summary
Researchers improved the rotavirus reverse genetics system for vaccine strain LLR, enhancing rescue efficiency and enabling stable expression of NLuc. This advancement aids rotavirus research and clinical applications.
Area of Science:
- Virology
- Molecular Biology
- Vaccinology
Background:
- Rotaviruses (RVs) are a major cause of severe gastroenteritis in young children.
- Species A rotaviruses have an 11-segmented double-stranded RNA genome.
- Previous work established a method to recover RV strain LLR using 11 plasmids.
Purpose of the Study:
- To improve the reverse genetics system for rotavirus vaccine strain LLR.
- To enhance the efficiency of rotavirus rescue and recombinant virus generation.
- To facilitate studies on rotavirus biology and clinical applications.
Main Methods:
- Developed a novel reverse genetics system by combining transcriptional cassettes (two or three) into single plasmids.
- Utilized the improved system to rescue rotavirus vaccine strain LLR.
- Generated a recombinant LLR strain stably expressing NLuc using a five-plasmid system.
Main Results:
- Achieved a significant enhancement in rescue efficiency from 66.7% (8/12) to 91.7% (11/12).
- Successfully rescued a recombinant LLR strain stably expressing NLuc.
- Demonstrated the improved system's effectiveness for generating genetically modified rotaviruses.
Conclusions:
- The optimized reverse genetics system substantially increases rotavirus rescue efficiency.
- This improved system is valuable for generating recombinant rotaviruses for research and potential clinical use.
- Advancements in rotavirus reverse genetics will accelerate studies on RV pathogenesis and vaccine development.

